InvestorPlace Research Staff

Recent Articles

Buy the Post-Earnings Dip in Alibaba Stock

Alibaba stock fell 6% after earnings were released on Friday morning. We've seen this story before: it always ends with BABA bouncing back.

Should You Sell Zoom Stock After Coronavirus? No, and Here’s Why

Zoom stock has been roaring higher this year, as business is booming. That makes ZM stock a buy on the dips. Let's look at why.

Does NASA Deal Make Virgin Galactic Stock a Buy?

Virgin Galactic has risk, but it's the perfect spec play. SPCE stock has big-time upside if things go right. Let's take a look.

Eight Companies Leading the Race for a COVID-19 Vaccine

The S&P 500 rallied to its best level in over two months this week as news surrounding the pandemic continues to improve. We’ll take it, right? In fact, since the dip a little over a week ago, the index has bounced 5%, thanks mostly to a huge rally on Monday. In this week’s MoneyLine podcast, we’ll dive into some interesting stocks that are breaking out and look ahead at what to expect the next couple of weeks. Monday’s surge came on positive news about a potential COVID-19 vaccine. I have been asked repeatedly about this the last few weeks, so in this episode I will break down the eight top contenders in the race for the first approved vaccine.

Undervalued Anheuser Busch Stock Has a Bad Case of Market Irrationality

So far, Anheuser Busch stock hasn’t been able to capitalize on increased alcohol demand from the coronavirus. However, it’s only a matter of time before the market realizes the logical opportunity in BUD.